Search company, investor...

Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
archventure.com

Investments

662

Portfolio Exits

114

Funds

16

Partners & Customers

1

Service Providers

1

About ARCH Venture Partners

ARCH Venture Partners is a provider of seed and early-stage venture capital for technology firms, with a special competence in co-founding and building firms from start-up. The firm's mission is to deliver promising technologies from the earliest stages to successful commercial application – from concept to commerce. ARCH Venture Partners was founded in 1986 and is based in Chicago, Illinois.

Headquarters Location

8755 W Higgins Road Suite 1025

Chicago, Illinois, 60631,

United States

773-380-6600

Want to inform investors similar to ARCH Venture Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing ARCH Venture Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find ARCH Venture Partners in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Research containing ARCH Venture Partners

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned ARCH Venture Partners in 7 CB Insights research briefs, most recently on Sep 19, 2022.

Latest ARCH Venture Partners News

08:00 ET ARCH Venture Partners Announces Appointment of Kevin Hrusovsky as Venture Partner

May 25, 2023

News provided by Share this article Share this article CHICAGO, May 25, 2023 /PRNewswire/ -- ARCH Venture Partners today announced the appointment of life sciences industry veteran Kevin Hrusovsky as Venture Partner. "Kevin has been instrumental in the success of multiple ARCH portfolio companies, and we look forward to building the next generation of companies together," said ARCH Co-founder and Managing Director Keith Crandell. "ARCH is committed to bringing the best entrepreneurs, experience, value-add perspective, and network to advance our portfolio companies. Kevin has deep experience in the industry and is an important addition to the ARCH team." "I am excited to join ARCH as a Venture Partner. We share a common goal of building world-class life science companies to help improve the health and wellbeing of society. I am honored to join the ARCH team," said Hrusovsky. Hrusovsky has a 30-year career leading life sciences companies. He currently serves as Chairman of 908 Devices and previously held the roles of Executive Chairman, Chairman, and President and CEO at Quanterix (QTRX). Prior to Quanterix, he was CEO of Caliper Life Sciences (CALP – acquired by PKI), and Zymark Corp. (acquired by CALP), as well as President of Life Sciences at PerkinElmer (PKI). He also held senior roles at FMC Corp. and DuPont. In addition, he created Powering Precision Health foundation, an international non-profit promoting innovations to achieve precision medicine. He is regarded as a pioneering entrepreneur, accelerating adoption and value creation for technologies enabling drug development and disease prevention. Hrusovsky is the recipient of several distinguished awards including the 2019 New England EY Entrepreneur of the Year® and has been recognized for innovations in medicine and health. He holds an M.B.A. from Ohio University, a B.S. in mechanical engineering from The Ohio State University and an Honorary Doctorate from Framingham State University. About ARCH Venture Partners ARCH Venture Partners creates and invests in ground-breaking life science and technology companies. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories. ARCH invests primarily in companies it co-founds with leading scientists and entrepreneurs, bringing innovations in life sciences and physical sciences to market. For more information, visit www.archventure.com . Contact:

ARCH Venture Partners Investments

662 Investments

ARCH Venture Partners has made 662 investments. Their latest investment was in Bitterroot Bio as part of their Series A on June 6, 2023.

CBI Logo

ARCH Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/7/2023

Series A

Bitterroot Bio

$145M

Yes

3

5/26/2023

Series B

Motion

$13.93M

Yes

2

5/18/2023

Series A - II

Myeloid Therapeutics

$73M

Yes

2

5/16/2023

Series C

Subscribe to see more

$99M

Subscribe to see more

10

5/12/2023

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/7/2023

5/26/2023

5/18/2023

5/16/2023

5/12/2023

Round

Series A

Series B

Series A - II

Series C

Series D

Company

Bitterroot Bio

Motion

Myeloid Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$145M

$13.93M

$73M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

2

2

10

10

ARCH Venture Partners Portfolio Exits

114 Portfolio Exits

ARCH Venture Partners has 114 portfolio exits. Their latest portfolio exit was CERo Therapeutics on June 05, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/5/2023

Acq - Pending

$99M

2

10/20/2022

IPO

$99M

Public

18

6/15/2022

Acquired

$99M

1

10/29/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

9/29/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/5/2023

10/20/2022

6/15/2022

10/29/2021

9/29/2021

Exit

Acq - Pending

IPO

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

18

1

10

10

ARCH Venture Partners Acquisitions

1 Acquisition

ARCH Venture Partners acquired 1 company. Their latest acquisition was Caliper Life Sciences on May 01, 1998.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/1/1998

Private Equity

$99M

$37.09M

Acquired

Date

5/1/1998

Investment Stage

Private Equity

Companies

Valuation

$99M

Total Funding

$37.09M

Note

Acquired

Sources

ARCH Venture Partners Fund History

16 Fund Histories

ARCH Venture Partners has 16 funds, including ARCH Venture Fund XII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/29/2022

ARCH Venture Fund XII

$3,000M

1

1/28/2021

ARCH Venture Fund XI

$1,850M

2

10/28/2019

ARCH Venture Fund X

Early-Stage Venture Capital

Open

$636M

3

10/25/2019

ARCH Venture Fund X Overage

$99M

10

11/18/2016

ARCH Venture Fund IX

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/29/2022

1/28/2021

10/28/2019

10/25/2019

11/18/2016

Fund

ARCH Venture Fund XII

ARCH Venture Fund XI

ARCH Venture Fund X

ARCH Venture Fund X Overage

ARCH Venture Fund IX

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$3,000M

$1,850M

$636M

$99M

$99M

Sources

1

2

3

10

10

ARCH Venture Partners Partners & Customers

1 Partners and customers

ARCH Venture Partners has 1 strategic partners and customers. ARCH Venture Partners recently partnered with JW Group on July 7, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

7/13/2022

Partner

United States

JW ties up with US venture capitalist for ‘R&D open innovation’

The JW Group partnered with U.S. venture capital ARCH Venture Partners to strengthen global open innovation .

1

Date

7/13/2022

Type

Partner

Business Partner

Country

United States

News Snippet

JW ties up with US venture capitalist for ‘R&D open innovation’

The JW Group partnered with U.S. venture capital ARCH Venture Partners to strengthen global open innovation .

Sources

1

ARCH Venture Partners Service Providers

1 Service Provider

ARCH Venture Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

ARCH Venture Partners Team

13 Team Members

ARCH Venture Partners has 13 team members, including , .

Name

Work History

Title

Status

Clinton W. Bybee

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Clinton W. Bybee

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare ARCH Venture Partners to Competitors

L
Lightspeed Venture Partners

Lightspeed Venture Partners operates as an early-stage venture capital firm. It focuses on accelerating disruptive innovations and trends in the enterprise and consumer sectors. It was founded in 2000 and is based in Menlo Park, California.

Sequoia Capital Logo
Sequoia Capital

Sequoia is a venture capital firm. It seeks to invest in companies operating in the information technology, healthcare, manufacturing, mobile, nanotechnology, financial service, internet, energy, media, and retail sectors. The company was founded in 1972 and is based in Menlo Park, California.

S
Slow Ventures

Slow Ventures is an early-stage focused venture capital firm. The firm invests in companies operating in commercial products, commercial services, consumer services, financial services, pharmaceuticals, and other sectors. It was founded in 2011 and is based in San Francisco, California.

SyndicateRoom Logo
SyndicateRoom

SyndicateRoom is an online equity crowdfunding platform that allows its members to co-invest in exciting companies with seasoned investors.

O
Osaka University Venture Capital

Osaka University Venture Capital (OUVC), associated with Osaka University, is focused on early-stage ventures in the fields of life innovation, green innovation, and platform technology.

R
Revolution

Revolution is a venture capital firm. It makes seed, early-stage, and growth equity investments. It was founded in 2005 and is based in Washington, DC.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.